Erythropoietin Receptor Positive Circulating Progenitor Cells and Endothelial Progenitor Cells in Patients with Different Stages of Diabetic Retinopathy
Chinese Medical Sciences JournalIssue 2, Pages: 69-76(2011)
Updated:2024-04-10
|
Share with wechat friends or circle of friends
Export references
Erythropoietin Receptor Positive Circulating Progenitor Cells and Endothelial Progenitor Cells in Patients with Different Stages of Diabetic Retinopathy
Affiliations:
1. Department of Ophthalmology,Peking Union Medical College Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College,Beijing,China,100730
2. Tongji Eye Instituteand Department of Regenerative Medicine, Tongji University School of Medicine,Shanghai,China,200092
3. Laboratory of Clinical Visual Sciences, Institute ofHealth Sciences, Shanghai Institutes for Biological Sciences, Chinese Academyof Sciences & Shanghai Jiao Tong University School of Medicine,Shanghai,China,200025
4. Department of Ophthalmology, Eye and ENT Hospital, FudanUniversity,Shanghai,China,200031
5. Department of Ophthalmology,Huashan Hospital Affiliated toFudan University,Shanghai,China,200040
6. Department ofOphthalmology,Ruijin HospitalAffiliated to Shanghai Jiao Tong University School of Medicine,Shanghai,China,200025
7. Department of Ophthalmology, Second Affiliated Hospital of Soochow University,Jiangsu,Suzhou,China,215004
8. Department of Ophthalmology, Drexel University College of Medicine, Philadelphia,PA,USA,19107
Author bio:
Funds:
DOI:
CLC:
Published Online:24 June 2011,
Published:2011
Accepted:
Scan QR Code
Liu-mei Hu, Xia Lei, Bo Ma, et al. Erythropoietin Receptor Positive Circulating Progenitor Cells and Endothelial Progenitor Cells in Patients with Different Stages of Diabetic Retinopathy[J]. Chinese medical sciences journal, 2011, (2): 69-76.
DOI:
Liu-mei Hu, Xia Lei, Bo Ma, et al. Erythropoietin Receptor Positive Circulating Progenitor Cells and Endothelial Progenitor Cells in Patients with Different Stages of Diabetic Retinopathy[J]. Chinese medical sciences journal, 2011, (2): 69-76.DOI:
Erythropoietin Receptor Positive Circulating Progenitor Cells and Endothelial Progenitor Cells in Patients with Different Stages of Diabetic Retinopathy
Objective To investigate the possible involvement of erythr opoietin (EPO)/erythropoietin receptor (EPOR) system in neovascularization and vascular regeneration in diabetic retinopathy (DR). Methods EPOR positive circulating progenitor cells (CPCs: CD34
+
) and endothelial progenitor cells (EPCs: CD34
+
KDR
+
) were assessed by flow cytometry in type 2 diabetic patients with different stages of DR. The cohort consisted of age- and sex-matched control patients with out diabetes ( n=7)
non-proliferative DR (NPDR
n=7)
non-proliferative DR (PDR
n=8)
and PDR complicated with diabetic nephr opathy (PDR-DN
n=7).Results The numbers of EPOR
+
CPCs and EPOR
+
EPCs were reduced remarkably in NPDR compared with the control group (both P<0.01)
whereas rebounded in PDR and PDR-DN groups in varyingdegrees. Similar changes were observed in respect of the proportion of EPOR
+
CPCs in CPCs (NPDR vs. control
P<0.01) and that of EPOR
+
EPCs in EPCs (NPDR vs. control
P<0.05).Conclusion Exogenous EPO
mediated via the EPO/EPOR system of EPCs
may alleviate the impaired vascular regeneration in NPDR
whereas it might aggravate retinal neovascularization in PDR due to a rebound of EPOR
+
EPCs associated with ischemia.
Abstract
Objective To investigate the possible involvement of erythr opoietin (EPO)/erythropoietin receptor (EPOR) system in neovascularization and vascular regeneration in diabetic retinopathy (DR). Methods EPOR positive circulating progenitor cells (CPCs: CD34
+
) and endothelial progenitor cells (EPCs: CD34
+
KDR
+
) were assessed by flow cytometry in type 2 diabetic patients with different stages of DR. The cohort consisted of age- and sex-matched control patients with out diabetes ( n=7)
non-proliferative DR (NPDR
n=7)
non-proliferative DR (PDR
n=8)
and PDR complicated with diabetic nephr opathy (PDR-DN
n=7).Results The numbers of EPOR
+
CPCs and EPOR
+
EPCs were reduced remarkably in NPDR compared with the control group (both P<0.01)
whereas rebounded in PDR and PDR-DN groups in varyingdegrees. Similar changes were observed in respect of the proportion of EPOR
+
CPCs in CPCs (NPDR vs. control
P<0.01) and that of EPOR
+
EPCs in EPCs (NPDR vs. control
P<0.05).Conclusion Exogenous EPO
mediated via the EPO/EPOR system of EPCs
may alleviate the impaired vascular regeneration in NPDR
whereas it might aggravate retinal neovascularization in PDR due to a rebound of EPOR
Effect of Intracoronary Infusion of Bone Marrow Mononuclear Cells or Peripheral Endothelial Progenitor Cells on Myocardial Ischemia-reperfusion Injury in Mini-swine
Association of C(-106)T Polymorphism in Aldose Reductase Gene with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes Mellitus
Related Author
Chong-jian Li
Ji-lin Chen and Jian-jun Li
Shu-bin Qiao
Ying-mao Ruan
Lai-feng Song
Shi-jie You
Wei-xian Yang
Feng-huan Hu
Related Institution
Center of Coronary Heart Disease
Department of Pathology, Fuwai Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College
Department of Ophthalmology, Fu Xing Hospital, Capital Medical University
Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology and Visual Sciences Key Laboratory